SCHEMBL2913339

SCHEMBL2913339

COC(=O)c1cc(-n2c(=O)cc[nH]c2=O)cc(C(C)(C)C)c1OC

nearest known ligand 0.34

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.34
KDM4E B2RXH2 3/20 0.34
MYC P01106 2/20 0.34
HPGD P15428 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
MAPT P10636 3/20 0.33
CHEK1 O14757 2/20 0.33
GAA P10253 2/20 0.32
LMNA P02545 2/20 0.32
KMT2A Q03164 1/20 0.32
CYP3A4 P08684 1/20 0.32
CRBN Q96SW2 1/20 0.32
TNFRSF1A P19438 1/20 0.31
NR4A2 P43354 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2915235 0.90 RARG (0.34) ALDH1A1KDM4EMYCHPGDMAPT
SCHEMBL2914850 0.84 KDM4E (0.35) ALDH1A1KDM4EMYCHPGDNPSR1
SCHEMBL2908251 0.81 ALDH1A1 (0.35) ALDH1A1KDM4EMYCHPGDNPSR1
SCHEMBL2913914 0.81 CRBN (0.42) ALDH1A1KDM4EHPGDMAPTKMT2A
SCHEMBL2915618 0.79 CYP3A4 (0.33) CYP3A4CRBNTNFRSF1A
SCHEMBL2907652 0.79 CYP3A4 (0.46) CHEK1CYP3A4CRBN
SCHEMBL2910784 0.79 CRBN (0.41) CHEK1CYP3A4CRBN
SCHEMBL2913574 0.78 RARB (0.39) CRBNTNFRSF1A
SCHEMBL1530145 0.76 CRBN (0.52) ALDH1A1KDM4EMYCHPGDNPSR1
SCHEMBL2318670 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222646-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C Abbott Laboratories (US) 2010-09-01 EP disclosed
EP-2203431-A1 ANTI-INFECTIVE PYRIMIDINES AND USES THEREOF Abbott Laboratories (US) 2010-07-07 EP disclosed
EP-2203430-A1 N-PHENYL-DIOXO-HYDROPYRIMIDINES USEFUL AS HEPATITIS C VIRUS (HCV) INHIBITORS Abbott Laboratories (US) 2010-07-07 EP disclosed
WO-2009039127-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C ABBOTT LABORATORIES (US) 2009-03-26 WO disclosed
WO-2009039135-A1 N-PHENYL-DIOXO-HYDROPYRIMIDINES USEFUL AS HEPATITIS C VIRUS (HCV) INHIBITORS ABBOTT LABORATORIES (US) 2009-03-26 WO disclosed
WO-2009039134-A1 ANTI-INFECTIVE PYRIMIDINES AND USES THEREOF ABBOTT LABORATORIES (US) 2009-03-26 WO disclosed